|By PR Newswire||
|February 12, 2014 06:30 AM EST||
ANAHEIM, Calif., Feb. 12, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release fourth quarter and full year 2013 financial results on Tuesday, February 25, 2014 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, February 25, 2014 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and corporate developments.
The call can be accessed in the following ways:
- By webcast: At Questcor's investor relations website, http://ir.questcor.com/.
- By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S. is (877) 354-0215. For participants outside the U.S., the dial-in number is (253) 237-1173.
- By audio replay: A replay of the conference call will be available for seven business days following conclusion of the live call. The telephone dial-in number for U.S. participants is (855) 859-2056. For participants outside the U.S., the replay dial-in number is (404) 537-3406. The replay access code for all callers is 55826448.
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor also provides specialty contract manufacturing services to the global pharmaceutical industry through its wholly-owned subsidiary BioVectra Inc. For more information about Questcor, please visit www.questcor.com.
SOURCE Questcor Pharmaceuticals, Inc.
Ovum, a leading technology analyst firm, has published an in-depth report, Ovum Decision Matrix: Selecting a DevOps Release Management Solution, 2016–17. The report focuses on the automation aspects of DevOps, Release Management and compares solutions from the leading vendors.
Jul. 29, 2016 12:00 PM EDT Reads: 1,823
Continuous testing helps bridge the gap between developing quickly and maintaining high quality products. But to implement continuous testing, CTOs must take a strategic approach to building a testing infrastructure and toolset that empowers their team to move fast. Download our guide to laying the groundwork for a scalable continuous testing strategy.
Jul. 29, 2016 12:00 PM EDT Reads: 2,086
Jul. 29, 2016 11:46 AM EDT
Jul. 29, 2016 11:30 AM EDT Reads: 1,215
Jul. 29, 2016 11:15 AM EDT Reads: 1,333
Jul. 29, 2016 11:15 AM EDT Reads: 665
Jul. 29, 2016 11:00 AM EDT Reads: 418
Jul. 29, 2016 11:00 AM EDT Reads: 493
Jul. 29, 2016 11:00 AM EDT Reads: 507
Jul. 29, 2016 11:00 AM EDT Reads: 781
Jul. 29, 2016 10:53 AM EDT Reads: 240
Jul. 29, 2016 10:45 AM EDT Reads: 487
Jul. 29, 2016 09:45 AM EDT Reads: 2,126
Jul. 29, 2016 09:45 AM EDT Reads: 1,027
Jul. 29, 2016 09:45 AM EDT Reads: 1,462